Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics to Offer Tests Through Salud Interactiva

NEW YORK (GenomeWeb) – Pathway Genomics has signed an agreement to make its next-generation sequencing-based clinical genetic tests available in Mexico through health services provider Salud Interactiva, the companies announced today.

Specific terms of the deal were not disclosed.

Pathway sells a variety of NGS assays including ones for diet and weight loss, circulating tumor DNA mutations, hereditary cancer, and carrier screening, as well as metabolic response for commonly prescribed medications.

"Our research determined that the wide range of tests that Pathway offers are at the forefront of the genetic revolution we are seeing in healthcare today that is driving the trend towards predictive medicine," Salud Interactiva CMO and COO Eduardo Càrdenas said in a statement. "Physicians and users within our network will now have affordable access to information about how their own genetic blueprint impacts their health."

About a year ago, Pathway announced that it had partnered with G-TAC and Sony subsidiary M3 to market a number of its tests in Japan.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.